{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T06:58:18Z","timestamp":1785653898081,"version":"3.56.0"},"reference-count":38,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\nBackground: <\/jats:title>\nMultiple sclerosis (MS)-Epstein\u2013Barr virus (EBV) relation is similar to doing a complicated puzzle: it consists of many pieces that become more and more clear as the issue is viewed from different sides. Based on the research findings, there is powerful evidence that EBV and MS have a strong relation where high levels of EBV DNA are able to be shown in all the spinal cord and the blood of the MS patients, but these are shown during disease relapses, and this implies a role in these illnesses. It kind of narrows the choices that you have to look for, just like how gathering evidence can lead to finding the missing person. In the analysis, new ways of EBV participation in MS progression are expected to be installed, and even new therapeutics are expected to be made.<\/jats:p>\n<\/jats:sec>\n\nMethods: <\/jats:title>\nA comprehensive literature search of PubMed was conducted until November 2023 to identify studies investigating the association between Epstein-Barr virus (EBV) infection and multiple sclerosis (MS). Only articles that met stringent criteria, including validation of EBV infection through laboratory testing, were included in the analysis.<\/jats:p>\n<\/jats:sec>\n\nResults: <\/jats:title>\nA total of 16 articles were identified as applicable for the background review, and this conformed with the discovery that the initiation of EBV\/IM was consistent across various studies, namely, retrospective, cross-sectional, or prospective. The statistics reveal a glimpse into the need for prolonged research in studying the pattern of this link between EBV and MS. Novel treatment approaches targeting EBV, including adoptive T-cell therapy and gene-based immunotherapy, show promise in mitigating MS progression by targeting EBV-infected cells.<\/jats:p>\n<\/jats:sec>\n\nConclusion: <\/jats:title>\nClinical trials investigating antiviral therapies and vaccination strategies are underway, aiming to translate these findings into effective treatments for MS. Despite promising advances, challenges remain in developing EBV-targeted therapies for MS, including safety concerns and the multifactorial nature of MS pathogenesis. Advance treatment options that focus on EBV, such as adoptive T-cell therapy and gene-based immunotherapy, are shown to be effective in the improvement of MS management that targets the viral-infected cell. The clinical trials for antiviral drugs and vaccination tactics are going on to benefit from these findings and eventually to invent effective therapeutics for MS. While these new therapeutic directions may offer great promise, challenges remain in these approaches as safety concerns and complex factors that underlie MS pathology need to be taken care of. The ethical aspects linked to picking the patients and giving informed consent make the progress of EBV-related treatments are even more difficult. Future research is recommended so that the primary mechanisms through which EBV contributes to MS development will be elucidated; in addition, the main MS subtype sources must be addressed. Longitudinal studies and other advanced research technologies will provide hope because they can solve the complicated problems of MS due to viruses and look for new therapeutic targets. The review brings up EBV\/IM disease as a vital aspect of MS susceptibility, encouraging research in the field of longitudinal studies. Although we have made advances, we are still far from clear on the labyrinthine pairing between EBV and MS and the development of therapeutic strategies to attack EBV infection in MS patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/sni_457_2024","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T10:42:23Z","timestamp":1728038543000},"page":"355","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epstein\u2013Barr virus flare: A multiple sclerosis attack"],"prefix":"10.25259","volume":"15","author":[{"given":"Ali Naser","family":"Msheik","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medical Sciences, Lebanese University, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Al Mokdad","sequence":"additional","affiliation":[{"name":"Masters In Medical Ethics, Registered Nurse, Lebanese University, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten","family":"Hamed","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Lebanese International University, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Assi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Lebanese University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jibbawi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saint Georges Hospital, Hadath, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Mohanna","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Khoury","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Lebanese University, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhamad","family":"Farhat","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Atat","sequence":"additional","affiliation":[{"name":"Professor of Neurology, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"10.25259\/SNI_457_2024\/ref-1","doi-asserted-by":"crossref","first-page":"a028944","DOI":"10.1101\/cshperspect.a028944","article-title":"Lifestyle and environmental factors in multiple sclerosis","volume":"1","author":"Alfredsson","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.25259\/SNI_457_2024\/ref-2","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: A prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"10.25259\/SNI_457_2024\/ref-3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr virus in multiple sclerosis: Theory and emerging immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.25259\/SNI_457_2024\/ref-4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.25259\/SNI_457_2024\/ref-5","doi-asserted-by":"crossref","first-page":"94497","DOI":"10.1371\/journal.pone.0094497","article-title":"Quantitative detection of Epstein-Barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis","volume":"10","author":"Cocuzza","year":"2014","journal-title":"PLoS One"},{"key":"10.25259\/SNI_457_2024\/ref-6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1474-4422(09)70275-3","article-title":"Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: A weighted genetic risk score","volume":"8","author":"De Jager","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.25259\/SNI_457_2024\/ref-7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/jnnp-2012-303068","article-title":"Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis","volume":"83","author":"D\u00e9card","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.25259\/SNI_457_2024\/ref-8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","article-title":"Epstein-Barr virus and multiple sclerosis: Evidence of association from a prospective study with long-term follow-up","volume":"63","author":"DeLorenze","year":"2006","journal-title":"Arch Neurol"},{"key":"10.25259\/SNI_457_2024\/ref-9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.msard.2017.07.009","article-title":"Season of infectious mononucleosis as a risk factor for multiple sclerosis: A UK primary care case-control study","volume":"17","author":"Downham","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.25259\/SNI_457_2024\/ref-12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/jech.2003.018366","article-title":"Multiple sclerosis after infectious mononucleosis: Record linkage study","volume":"58","author":"Goldacre","year":"2004","journal-title":"J Epidemiol Community Health"},{"key":"10.25259\/SNI_457_2024\/ref-13","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/ene.15407","article-title":"Free vitamin D3 index and vitamin D-binding protein in multiple sclerosis: A presymptomatic case-control study","volume":"29","author":"Grut","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.25259\/SNI_457_2024\/ref-14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.245462","article-title":"The role of Epstein-Barr virus in multiple sclerosis: From molecular pathophysiology to in vivo imaging","volume":"14","author":"Guan","year":"2019","journal-title":"Neural Regen Res"},{"key":"10.25259\/SNI_457_2024\/ref-15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135245859500100203","article-title":"Increased risk of multiple sclerosis after late Epstein-Barr virus infection: A historical prospective study","volume":"1","author":"Haahr","year":"1995","journal-title":"Mult Scler"},{"key":"10.25259\/SNI_457_2024\/ref-16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat Genet"},{"key":"10.25259\/SNI_457_2024\/ref-17","doi-asserted-by":"crossref","first-page":"e0192109","DOI":"10.1371\/journal.pone.0192109","article-title":"Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells","volume":"13","author":"Hassani","year":"2018","journal-title":"PLoS One"},{"key":"10.25259\/SNI_457_2024\/ref-18","doi-asserted-by":"crossref","first-page":"1212676","DOI":"10.3389\/fimmu.2023.1212676","article-title":"Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection","volume":"24","author":"Hedstr\u00f6m","year":"2023","journal-title":"Front Immunol"},{"key":"10.25259\/SNI_457_2024\/ref-19","first-page":"325","article-title":"Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage","volume":"95","author":"Jons","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.25259\/SNI_457_2024\/ref-20","doi-asserted-by":"crossref","first-page":"103572","DOI":"10.1016\/j.ebiom.2021.103572","article-title":"The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype","volume":"71","author":"Keane","year":"2021","journal-title":"EBioMedicine"},{"key":"10.25259\/SNI_457_2024\/ref-21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.25259\/SNI_457_2024\/ref-22","doi-asserted-by":"crossref","first-page":"e1438","DOI":"10.1002\/cti2.1438","article-title":"Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials","volume":"12","author":"Lanz","year":"2023","journal-title":"Clin Transl Immunology"},{"key":"10.25259\/SNI_457_2024\/ref-23","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"10.25259\/SNI_457_2024\/ref-24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000110248","article-title":"Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis","volume":"10","author":"Lindberg","year":"1991","journal-title":"Neuroepidemiology"},{"key":"10.25259\/SNI_457_2024\/ref-25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12876-022-02118-y","article-title":"Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: A retrospective cohort study of 29,553 outpatients in Germany","volume":"5","author":"Loosen","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.25259\/SNI_457_2024\/ref-26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.25259\/SNI_457_2024\/ref-27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","article-title":"Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis","volume":"67","author":"L\u00fcnemann","year":"2010","journal-title":"Ann Neurol"},{"key":"10.25259\/SNI_457_2024\/ref-28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.0b013e3181c0d6e0","article-title":"Body size and risk of MS in two cohorts of US women","volume":"10","author":"Munger","year":"2009","journal-title":"Neurology"},{"key":"10.25259\/SNI_457_2024\/ref-29","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: A prospective study among United States military personnel","volume":"17","author":"Munger","year":"2011","journal-title":"Mult Scler"},{"key":"10.25259\/SNI_457_2024\/ref-30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneur.64.1.72","article-title":"Multiple sclerosis after infectious mononucleosis","volume":"64","author":"Nielsen","year":"2007","journal-title":"Arch Neurol"},{"key":"10.25259\/SNI_457_2024\/ref-32","doi-asserted-by":"crossref","first-page":"103563","DOI":"10.1016\/j.msard.2022.103563","article-title":"Identification of multiple sclerosis-related genes regulated by EBV-encoded micrornas in B cells","volume":"59","author":"Rang","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.25259\/SNI_457_2024\/ref-33","doi-asserted-by":"crossref","first-page":"103211","DOI":"10.1016\/j.ebiom.2021.103211","article-title":"Identification of two highly antigenic epitope markers predicting multiple sclerosis in optic neuritis patients","volume":"64","author":"Sadam","year":"2021","journal-title":"EBioMedicine"},{"key":"10.25259\/SNI_457_2024\/ref-34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish national patient registry: A review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.25259\/SNI_457_2024\/ref-35","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"26","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"10.25259\/SNI_457_2024\/ref-36","doi-asserted-by":"crossref","first-page":"e1444","DOI":"10.1002\/cti2.1444","article-title":"Adoptive T-cell therapy targeting Epstein-Barr virus as a treatment for multiple sclerosis","volume":"12","author":"Smith","year":"2023","journal-title":"Clin Transl Immunol"},{"key":"10.25259\/SNI_457_2024\/ref-37","doi-asserted-by":"crossref","first-page":"64868","DOI":"10.1371\/journal.pone.0064868","article-title":"Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation","volume":"27","author":"Smith","year":"2013","journal-title":"PLoS One"},{"key":"10.25259\/SNI_457_2024\/ref-38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.25259\/SNI_457_2024\/ref-39","doi-asserted-by":"crossref","first-page":"1009618","DOI":"10.1371\/journal.ppat.1009618","article-title":"Epigenetic plasticity enables CNS-trafficking of EBV-infected B lymphocytes","volume":"9","author":"Soldan","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.25259\/SNI_457_2024\/ref-42","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.1038\/s41598-022-11444-w","article-title":"Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome","volume":"9","author":"Umeton","year":"2022","journal-title":"Sci Rep"},{"key":"10.25259\/SNI_457_2024\/ref-43","doi-asserted-by":"crossref","first-page":"e2124932","DOI":"10.1001\/jamanetworkopen.2021.24932","article-title":"Association of infectious mononucleosis in childhood and adolescence with risk for a subsequent multiple sclerosis diagnosis among siblings","volume":"1","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/epsteinbarr-virus-flare-a-multiple-sclerosis-attack\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/epsteinbarr-virus-flare-a-multiple-sclerosis-attack\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T10:42:36Z","timestamp":1728038556000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/epsteinbarr-virus-flare-a-multiple-sclerosis-attack\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":38,"alternative-id":["10.25259\/SNI_457_2024"],"URL":"https:\/\/doi.org\/10.25259\/sni_457_2024","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"article-number":"355"}}